日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure

乌帕替尼可使既往托法替尼治疗失败的炎症性肠病患者达到内镜下缓解。

期刊:Journal of Clinical Gastroenterology
影响因子:2.7
doi:10.1097/MCG.0000000000002157
Lee, Scott David; Kamp, Kendra J; Jacobs, Jeffrey; Harper, Jason; Barahimi, Mitra; Clark-Snustad, Kindra Dawn
炎症/感染
炎症
发表日期：2026
文献求助 收藏

Discordance between endoscopic and histopathologic assessment in ileal Crohn's disease

回肠克罗恩病内镜评估与组织病理学评估结果不一致

期刊:World Journal of Gastrointestinal Endoscopy
影响因子:1.8
doi:10.4253/wjge.v17.i2.101284
Lee, Scott D; Mau, Brian; Avalos, Cody J; Clark-Snustad, Kindra D; Kamp, Kendra J; Gui, Xianyong
克罗恩病
发表日期：2025
文献求助 收藏

Mycophenolate Mofetil Appears Effective for the Treatment of Patients With Refractory Crohn's Disease

吗替麦考酚酯对治疗难治性克罗恩病患者似乎有效

期刊:Crohns Colitis 360
影响因子:2.6
doi:10.1093/crocol/otae067
Rosenfeld, Sam; Clark-Snustad, Kindra; Kamp, Kendra J; Jacobs, Jeffrey; Barahimi, Mitra; Harper, Jason; Lee, Scott David
克罗恩病
发表日期：2024
文献求助 收藏

A Comprehensive Self-Management Intervention for Inflammatory Bowel Disease (CSM-IBD): Protocol for a Pilot Randomized Controlled Trial

炎症性肠病综合自我管理干预（CSM-IBD）：一项试点随机对照试验方案

期刊:JMIR Research Protocols
影响因子:1.5
doi:10.2196/46307
Kamp, Kendra; Clark-Snustad, Kindra; Yoo, Linda; Winders, Samantha; Cain, Kevin; Levy, Rona L; Dey, Neelendu; Lee, Scott; Keefer, Laurie; Heitkemper, Margaret
炎症/感染
CSM
炎症
发表日期：2023
文献求助 收藏

Relationship of Sleep Health and Endoscopic Disease Activity in Inflammatory Bowel Disease: Endoscopic Disease Activity and Sleep

睡眠健康与炎症性肠病内镜疾病活动度的关系：内镜疾病活动度和睡眠

期刊:Gastroenterology Nursing
影响因子:0.8
doi:10.1097/SGA.0000000000000769
Kamp, Kendra J; Yoo, Linda; Clark-Snustad, Kindra; Winders, Samantha; Burr, Robert; Buchanan, Diana; Barahimi, Mitra; Jacobs, Jeffrey; Heitkemper, Margaret; Lee, Scott D
炎症/感染
炎症
发表日期：2023
文献求助 收藏

Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease

托法替尼联合生物制剂治疗难治性克罗恩病的安全性和有效性

期刊:Inflammatory Bowel Diseases
影响因子:4.3
doi:10.1093/ibd/izab176
Lee, Scott David; Singla, Anand; Harper, Jason; Barahimi, Mitra; Jacobs, Jeffrey; Kamp, Kendra J; Clark-Snustad, Kindra Dawn
克罗恩病
发表日期：2022
文献求助 收藏

Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease

系统评价与荟萃分析：生物制剂与小分子药物联合治疗炎症性肠病的安全性和有效性

期刊:Crohns Colitis 360
影响因子:2.6
doi:10.1093/crocol/otac002
Alayo, Quazim A; Fenster, Marc; Altayar, Osama; Glassner, Kerri L; Llano, Ernesto; Clark-Snustad, Kindra; Patel, Anish; Kwapisz, Lukasz; Yarur, Andres J; Cohen, Benjamin L; Ciorba, Matthew A; Thomas, Deborah; Lee, Scott D; Loftus, Edward V Jr; Fudman, David I; Abraham, Bincy P; Colombel, Jean-Frederic; Deepak, Parakkal
炎症/感染
炎症
发表日期：2022
文献求助 收藏

Case Series: Re-induction of Intravenous, Weight-Based Ustekinumab Is Well Tolerated in Patients With Moderate-Severe Crohn's Disease

病例系列：中重度克罗恩病患者对基于体重的静脉注射乌司奴单抗再诱导治疗耐受性良好

期刊:Crohns Colitis 360
影响因子:2.6
doi:10.1093/crocol/otac012
Lee, Scott David; Kamp, Kendra; Clark-Snustad, Kindra Dawn
克罗恩病
发表日期：2022
文献求助 收藏

Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease

托法替尼对难治性克罗恩病患者具有良好的耐受性和疗效。

期刊:Digestive Diseases and Sciences
影响因子:2.5
doi:10.1007/s10620-022-07444-5
Lee, Scott David; Singla, Anand; Harper, Jason; Barahimi, Mitra; Jacobs, Jeffrey; Kamp, Kendra J; Clark-Snustad, Kindra Dawn
克罗恩病
发表日期：2022
文献求助 收藏

Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease

炎症性肠病中内镜和临床疾病活动度与疲劳的关系

期刊:Gastroenterology Nursing
影响因子:0.8
doi:10.1097/SGA.0000000000000600
Kamp, Kendra J; Clark-Snustad, Kindra; Barahimi, Mitra; Lee, Scott
炎症/感染
炎症
发表日期：2022
文献求助 收藏